Skip to main content

Table 1 Baseline Clinical Characteristics and Medications

From: Alterations in arterial function after high-voltage electrical injury

 

HVEI group

(n= 25)

Control group

(n= 25)

P-Value

Age (years)

48 ± 11

48 ± 11

0.94

Hypertension

6 (24%)

7 (28%)

0.75

Current smoking

14 (56%)

9 (36%)

0.26

Body mass index (Kg/m2)

23.6 ± 2.6

23.6 ± 2.0

0.99

Hemoglobin (gm/dL)

14.7 ± 1.1

14.9 ± 1.1

0.62

Glucose (mg/dL)

110 ± 18

90 ± 11

< 0.01

Total cholesterol (mg/dL)

175 ± 27

185 ± 26

0.18

Creatinine (mg/dL)

0.8 ± 0.2

0.8 ± 0.1

0.65

High-sensitive C-reactive protein (mg/dL)

51.2 ± 43.2

0.9 ± 0.6

< 0.01

Aspirin

2 (8%)

5 (20%)

0.42

Beta-blocker

1 (4%)

2 (8%)

1.00

ACEI/ARB

2 (8%)

5 (20%)

0.42

Calcium channel blocker

6 (24%)

3 (12%)

0.46

Statin

1 (4%)

4 (16%)

0.35

  1. ACEI/ARB, angiotensin converting enzyme inhibitor/angiotensin receptor blocker; HVEI, high-voltage electrical injury.